Analyst Information for Novavax Inc.

$ 94.36   -1.94 (-2.01%) Volume: 3.07m 4:00 PM EDT 10-Jul-2020
After Hours:  $ 94.55   0.19 (+0.20%) Volume: 17.66k 7:59 PM EDT 10-Jul-2020
Consensus Rating Average
Consensus Rating for NVAX is MODERATE BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 1.86
Previous Average Recommendation 1.50
Change in Average Recommendation 0.36
Number of Analysts Reporting 7
Strong Buy
1.0
Current: 1.86
Previous: 1.50
Change: 0.36
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 395
Rank Recommendation relative to companies in its industry 297
Ranked 297 in Industry
1395 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 4
Analysts recommending Moderate Buy 0
Analysts recommending Hold 3
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 6 6 6
Moderate Buy 0 0 0 0
Hold 3 2 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.86 1.50 1.29 1.29

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.